Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Non-squamous Non-Small-Cell Lung Cancer × nedaplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 12 Esophageal Squamous Cell Carcinoma 7 Esophageal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrence 1 Neoplasms 1 Immunotherapy Esophagus Cancer 1 Hypopharyngeal Neoplasms 1 Hepatic Artery Infusion 1 Head and Neck Neoplasms 1 Advanced Non-squamous Non-Small-Cell Lung Cancer 1

Interventions

sintilimab 1 nedaplatin 1 Pemetrexed 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05648071 2022-12-13

SPBPDC

Qianfoshan Hospital

Phase 3 Unknown

Advanced Non-squamous Non-Small-Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡